In recent years, the favor of capital and the pursuit of consumers have made light medical beauty , which "beauty, not to use a knife", ushered in rapid development, and even surpassed the traditional medical beauty .
Light medical beauty is so popular, which has also driven the rapid growth of medical beauty segments such as injection-based hyaluronic acid. Data from Frost & Sullivan shows that from 2016 to 2020, the compound growth rate of the market size of hyaluronic acid terminal products in China exceeded 25%; from 2020 to 2025, the compound growth rate is expected to remain at 20.6%.
The rapid growth of "appearance economy" has pushed a long-term low-key company to the forefront. Faced with the potential market, this company chose to take decisive action.
Recently, the signing ceremony of the strategic partnership of plastic surgery of Tongji Hospital affiliated to Hekang Biotechnology & Tongji University and the establishment and listing ceremony of the Futaden Injection Education and Training Base were held at Shanghai Tongji Hospital.
At this ceremony, Cui Haiyan, professor of plastic surgery from Tongji Hospital affiliated to Tongji University, Ni Jieli, general manager of Shanghai Company of Hekang Biotechnology Technology Co., Ltd., and Jiang Yan, director of China Operations, all attended the ribbon cutting ceremony.
Hekangshengtech Technology Co., Ltd. Shanghai General Manager Ni Jieli (third from right), Professor Cui Haiyan (second from left), Operation Director of China of Tongji Hospital Affiliated to Tongji University, Jiang Yan (first from left), and other guests unveiled the training base for the training base
As a low-key Taiwanese company, this is Hekangshengtech's first public appearance after establishing a company in Shanghai. Ni Jieli regards this cooperation as the beginning of Hekang Biotechnology's academic foothold in the market. In an interview, she said that her cooperation with the Department of Plastic Surgery at Tongji Hospital Affiliated to Tongji University hit it off.
This cooperation originated from the oriental aesthetic advocated by Professor Cui Haiyan and the "future" design concept proposed by him first. This concept is very consistent with Hekang Biotech's "soft and beauty" concept.
Professor Cui Haiyan said that through this cooperation, both parties will work together to cultivate practitioners and deepen their aesthetics of technology, including artistic creation and in-depth understanding of the medical beauty industry.
"We hope to help the concept of 'new and healthy, new future'." He said.
Fu's new starting point for Hekang Biotechnology
This time, Fu Ya Deng, who cooperated with both sides, is a major ace product of Hekang Biotechnology and a pioneer in the entire series of Hekang Hyaluronic Acid products on the mainland. As a crosslinked sodium hyaluronate gel product for injection, Funden is currently in the hottest hyaluronic acid track for injection.
Professor Cui Haiyan of Plastic Surgery Department of Tongji Hospital Affiliated to Tongji University and Ni Jieli, General Manager of Hekang Biotechnology Shanghai Company, signed a cooperation agreement
Hyaluronic Acid, also known as hyaluronic acid (HA), is a sulfur-free acid mucopolysaccharide, widely distributed in the human body's connective tissue , epithelial tissue and neural tissue . Because its hyaluronic molecules can carry more than 500 times the moisture, it is known as the ideal natural moisturizing factor.
The main use of hyaluronic acid for injection in medical beauty is hyaluronic acid, which is hyaluronic acid with a larger molecular weight, which has stronger support, resistance to decline and viscoelasticity. And Fu's wife is like this.
Light medical beauty has the characteristics of "small risk, low threshold, high frequency and low price". In recent years, it has vaguely competed with traditional surgical medical beauty. In the sub-track, hyaluronic acid injection projects with simple operation, obvious effects and short recovery period have become the first choice for many beauty seekers.
"There are countless hyaluronic acid brands on the market," according to Professor Cui Haiyan: "There are more than 50 kinds of hyaluronic acid approved for use in China, which is very common in clinical practice."
from Hekang Biotechnology's Fun is in the mainland market, not a latecomer. As early as 2016, Fu Yaden obtained a CFDA marketing license in mainland China, suitable for mid-layer injection of facial dermal tissue to correct moderate to severe nasolabial fold wrinkles.
At that time, Fu'an Ding had a good reputation in many medical beauty clinics and medical institutions. At that time, the medical beauty market was still in its infancy. In the public's mind, medical beauty was still a "luxury product". Therefore, Fu'an Ding was just a word of mouth between doctors and beauty seekers.
In this regard, Ni Jieli said that Hekang Biotech has always been very focused on product research and development and production, and has relatively little investment in market promotion, mainly relying on the natural growth of the market. The turning point came from July last year, when Hekang Biotech was acquired by Dajiang Biotechnology, a biointegrated design and manufacturing company founded in 1980 and headquartered in Taiwan.
is such a new opportunity. Hekang Biotech has established a professional team for the mainland market in Shanghai, preparing to open up this medical beauty consumer market with broad prospects and wild growth.
Thankfully, Hekang Biotech is facing a market with more comprehensive supervision, and Futaden, which has complete international certifications, is expected to enjoy the compliance market bonus .
Before 2022, hyaluronic acid products were in a wild growth stage. The reason was that the prices were opaque, many brands, and fierce competition. Due to the chaotic medical beauty market in the early stage and the irregular supply and circulation channels, the sub-track of hyaluronic acid for injection was still in its infancy.
With the National Medical Products Administration clearly used in March this year for injection sodium hyaluronate solution for injection into the dermis, it must be regulated in accordance with Class 3 medical devices . A stricter policy and standardized market will bring a fairer and transparent market environment to manufacturers that operate in compliance.
If the chaotic market was accidentally easily "smeared" competitive and quality-guaranteed products in the market, then now, for regular manufacturers, it is the time to witness their true strength.
In the interview, Professor Cui Haiyan also expressed his affirmation of Fu Yam's quality: "Fu Yam's product is very suitable for highly professional clinicians in terms of use. Whether it is in terms of bore concentration or the immediate effect of the product, it can well reflect the bone nature of the beauty seeker. The instant effect after injection is natural, there is no edema and inflammation after injection, and no displacement or swelling occurs. It has shown the concept of humanistic medical beauty and healthy medical beauty from the product to the product."
0 Professor Cui Haiyan, a plastic surgery department of Tongji Hospital Affiliated to Tongji University, spoke at the signing ceremony
Ni Jieli said: "Fuyi Deng has its own differentiation compared to other products. Excellent product quality, stable supply chain and academic status are its biggest competitive advantages." In her opinion, this cooperation with Professor Cui Haiyan, who is famous at home and abroad in the field of plastic surgery, is expected to rely on the academic strength of plastic surgery department of Tongji Hospital Affiliated to Tongji University, which will help greatly enhance the recognition of Fuyi Deng's brand and have a greater share in the market.
Hekangsheng Technology Technology Co., Ltd. China Operation Director Jiang Yan awarded Professor Cui Haiyan and Kangdongfang Meiyuan Chief Lecturer Certificate
The highest level of practicing medical beauty
Short-term commercial returns are not the only goal. Hekangsheng Technology set up a bigger game of chess this time. Ni Jieli said that our greater ambition is to innovate the aesthetic concept of the medical beauty industry, which requires the participation of the entire industry. We hope everyone will explore together.
"We especially hope to introduce academic power. We hope that when the product is applied to beauty seekers, we can have doctors with sufficient experience and aesthetic standards to fully utilize the product's advantages." Ni Jieli said.
As the director of plastic surgery department of Tongji Hospital Affiliated to Tongji University, Professor Cui Haiyan is such a leader. His "Oriental Aesthetic" concept coincides with the "Oriental Soft and Sculpting Beauty" concept advocated by Fu Teden.
In recent years, China's medical beauty market has flourished. However, when the technical level continues to rise, it is not difficult for us to find that since early medical beauty products, methods and concepts all come from the West, China cannot help but emulate. Whether it is European and American, Korean or Japanese, all kinds of "Internet celebrity faces" that are popular are sought after by those who seek beauty.
The industry that should have created beauty, but has been copying beauty. This has become a regret for the current medical beauty industry.
In Professor Cui Haiyan's view, Medical beauty has three levels of realm:
The first level: be able to master basic theories, basic anatomy, basic technology, basic equipment and product applications, and solve basic problems;
The second level: proficient in anatomy and technology, as well as the use of equipment and products, can solve complex problems, effectively prevent and deal with complications;
The third level: regard medical beauty as artistic creation under medical restrictions, so as to discover and create potential personalized beauty for those who seek beauty.
And this last third level is exactly what many doctors cannot achieve nowadays. "In addition to technology, what the industry needs more now is an artistic and humanistic construction." Professor Cui Haiyan was quite moved.
In fact, since 2007, Professor Cui Haiyan has spared no effort to advocate "Oriental aesthetics" at home and abroad. He first published an article to propose the concept of "the overall image design and construction of human aesthetics", and then proposed the "future" design concept of facial injection beauty and aesthetics.
"I summarized the oriental aesthetics and the medical beauty solutions with it as the core into the words "future", which are also the two most beautiful words in Chinese culture." Professor Cui Haiyan said.
Specifically, "wei" is composed of the midline - from the Yintang to the root of the nose, the bridge of the nose, the tip of the nose, the lips, chin, temples and eyebrow arch, the horizontal line of apple muscle , and the strokes of nasolabial folds. And the two points of the tear trough are added to the word "come". He pointed out that a large number of clinical practices have proved that the design concept of "future" is both simple and practical in the eastern aspect.
It is true that medical beauty and aesthetics are integrated. How to aesthetically beautify in the era of medical beauty may be a topic that all medical beauty institutions and platforms should think more.
At present, as the medical beauty industry gradually standardizes from a chaotic state, this track has returned to its former vitality. Large enough market space attracts wave after wave of gold nuggets. Jiang Yan, Operation Director of Hekang Biotech China, said: "Hekang Biotech is no exception. Xinhekang, the new future is not just a slogan, it is also the responsibility of all Hekang people. With the support of the company's high-end R&D, we can bring ripples to the future compliant medical beauty market, and even an innovation. We also hope to become one of the leaders in this industry with the most professional attitude."
For the future, Ni Jieli expressed her continued optimism and will fully embrace the medical beauty track. "Our market development focus will still be hyaluronic acid and collagen or some new materials combined." She said, "Starting from 2023, Hekang Biotech will continue to improve its products and production lines, and more new certificates are on the way."
Guests took a photo with the conference
Industry heavy content and policy information were obtained in a timely manner. Scan the QR code to follow the Yigu WeChat official account
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-